Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial

Fig. 3

Overall survival curves for subgroups. Kaplan–Meier curves of overall survival for patients with ALC Nadir ≥ 0.24*109/L or < 0.24*109/L, for patients with Pretreatment NLR ≥ 3.4 or < 3.4, for patients with V30 of Heart ≥ 11.4% or < 11.4%, and for patients with MHD ≥ 7.75 Gy or < 7.75 Gy, respectively

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us